Follow The Filings

ANGO Angiodynamics Inc.

Health Care, filed as ANGIODYNAMICS INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

  • 1 Owner
  • Max 0.0%
  • $3.6M
  • 1 add

In 2026 Q2 First Eagle Investment Management added to Angiodynamics.

Who owns this now

Largest portfolio weights among holders, up to 0.0% (First Eagle Investment Management). Not free-float ownership.

  1. First Eagle Investment Manage... Add 0.01%

Who owns ANGO

Sorted by value, long equity only, as of 2026 Q2.

History
First Eagle Investment Management 0.01% Add +0.3% 276,435 $3.6M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by ANGO's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ANGO insider trades
  • None no insider bought on the open market
  • $344K sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Warren Nighan Jr. SVP Quality and Regulatory
    Sale
    $344K 23,370 shares at $14.72 27% of stake
    Traded Jul 30 Filed Jul 31
    ↗
  2. Lawrence T Weiss SVP, Chief Legal Officer
    Buy
    $118K 10,000 shares at $11.81 +12% to stake
    Traded Oct 21, 2025 Filed Oct 22, 2025
    ↗
  3. Stephen A Trowbridge CFO
    Buy
    $9,932 890 shares at $11.16 +0.3% to stake
    Traded Oct 13, 2025 Filed Oct 14, 2025
    ↗
  4. James C Clemmer CEO
    Buy
    $112K 10,000 shares at $11.15 +1.1% to stake
    Traded Oct 9, 2025 Filed Oct 9, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 23 share withholdings for taxes, 12 stock grants, and 5 option exercises.

Congress

1 member of Congress traded ANGO in the last three years: 1 buy and 2 sales. 1 member listed it in 2025 annual reports.

All Congress trades
  1. Debbie Wasserman Schultz D-FL-25Child Sell $2,000 Oct 20, 2025 filed Oct 24, 2025
  2. Debbie Wasserman Schultz D-FL-25 Sell $1K–$15K Jul 16, 2025 filed Jul 25, 2025
  3. Debbie Wasserman Schultz D-FL-25Child Buy $1K–$15K Jun 27, 2025 filed Jul 25, 2025

SEC filings

Recent issuer filings from EDGAR, 16 shown.

Filed Form Detail Links
DEF 14A Filing Doc
10-Q Filing Doc
DEFA14A Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
8-K 1.01,5.02,9.01 Filing Doc
10-K/A Filing Doc
10-K/A Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-K Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 8.01 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc

Source: SEC EDGAR submissions, updated 12 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025 FY2026
Revenue $338.75M $303.91M $292.5M $320.17M
Gross profit $174.25M $154.7M $157.7M $174.89M
Gross margin * 51.4% 50.9% 53.9% 54.6%
Net income -$52.44M -$184.35M -$33.99M -$36.74M
Net margin * -15.5% -60.7% -11.6% -11.5%

Balance sheet

Metric FY2023 FY2024 FY2025 FY2026
Total current assets $163.54M $193.25M $168.32M $163.39M
Total non-current assets * $369.1M $124.42M $111.82M $103.77M
Total assets $532.64M $317.67M $280.14M $267.16M
Total current liabilities $83.82M $91.16M $76.2M $74.72M
Total non-current liabilities * $70.52M $20.93M $20.98M $21.62M
Total equity $378.3M $205.59M $182.97M $170.82M

Cash flow

Metric FY2023 FY2024 FY2025 FY2026
Cash from operations $0.078M -$28.16M -$10.13M $3.09M
Cash from investing -$9.75M $123.72M -$10.18M -$5.95M
Cash from financing $25.42M -$64.25M -$0.255M $0.564M
Net change in cash $15.8M $31.44M -$20.16M -$2.03M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.